Improv + ERP Therapy for OCD

N/A

Recruiting

Led By Carolyn Rodriguez, MD, PhD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least 18 years of age

Clinical diagnosis of obsessive-compulsive disorder (OCD)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and up to 12 weeks

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to test a new group therapy for adults with OCD."

Who is the study for?

This trial is for adults over 18 who can speak and understand English and have been diagnosed with Obsessive-Compulsive Disorder (OCD). It's not suitable for individuals currently having suicidal thoughts or those with medical or psychiatric conditions that could affect their participation.

What is being tested?

The study is testing a new group therapy method that combines Exposure Response Prevention (ERP) with improvisational group psychotherapy to see if it helps people with OCD.

What are the potential side effects?

Since this is a psychotherapy intervention, there may not be physical side effects like in drug trials. Participants might experience emotional discomfort or anxiety as they confront OCD-related fears during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have been diagnosed with obsessive-compulsive disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and up to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and up to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in the severity of OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (YBOCS)

Secondary study objectives

Change in Intolerance of Uncertainty Score

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: ERP combined with Improv Group TherapyExperimental Treatment2 Interventions

Participants will attend 90-minute ERP + improv group therapy sessions for 12 consecutive weeks. They will also complete homework between sessions, answer questions, and complete questionnaires.

0 / 2Eligibility criteria met